Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection

NCT07536282 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent HPV16 Infection

Interventions

BIOLOGICAL: NWRD09
BIOLOGICAL: Placebo

Sponsor

Newish Biotech (Wuxi) Co., Ltd.